biotech

Bayer Takes Over Schering

Filed in archive Corporate and Industrial News on June 16, 2006

Bayer Takes Over Schering
It seems that after a minor hiccup, Bayer does take over Schering after reaching a settlement with Merck.
Bayer AG is to acquire the entire 21,8% stake in Schering shares held by Merck. The purchase price is EUR 89 per share.

Conceding to Bayer, Merck says it is now keen to cooperate with Bayer, particularly in in the fields of oncology, Cardiology or diabetes.
The cost of the deal, which reached almost $22 billion, is however speculated to lead to cost pressures and potential job cuts at Schering. Click the image or here see a video report from Reuters.

Permalink: Bayer Takes Over Schering

Tags: merger  schering  biotech  bayer  over  over+schering  bayer+takes  takes+over 

Vote for Bayer Takes Over Schering:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 2 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells